Zobrazeno 1 - 10
of 383
pro vyhledávání: '"Marina Chiara Garassino"'
Autor:
Mingchao Xie, Miljenka Vuko, Jaime Rodriguez-Canales, Johannes Zimmermann, Markus Schick, Cathy O’Brien, Luis Paz-Ares, Jonathan W. Goldman, Marina Chiara Garassino, Carl M. Gay, John V. Heymach, Haiyi Jiang, J. Carl Barrett, Ross A. Stewart, Zhongwu Lai, Lauren A. Byers, Charles M. Rudin, Yashaswi Shrestha
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-17 (2024)
Abstract Background We explored potential predictive biomarkers of immunotherapy response in patients with extensive-stage small-cell lung cancer (ES-SCLC) treated with durvalumab (D) + tremelimumab (T) + etoposide-platinum (EP), D + EP, or EP in the
Externí odkaz:
https://doaj.org/article/dac90161c2bf43f78841723ad0ac6b3b
Autor:
Valeria Sebri, Chiara Marzorati, Patrizia Dorangricchia, Dario Monzani, Roberto Grasso, Arsela Prelaj, Leonardo Provenzano, Laura Mazzeo, Andra Diana Dumitrascu, Jana Sonnek, Marlen Szewczyk, Iris Watermann, Francesco Trovò, Nina Dollis, Evangelos Sarris, Marina Chiara Garassino, Christine M. Bestvina, Alessandra Pedrocchi, Emilia Ambrosini, Sokol Kosta, Enriqueta Felip, Mireia Soleda, Aina Arbusà Roca, Jose Rodríguez‐Morató, Alessandro Nuara, Yonah Lourie, Melissa Fernandez‐Pinto, Alfonso Aguaron, Gabriella Pravettoni
Publikováno v:
Cancer Medicine, Vol 13, Iss 9, Pp n/a-n/a (2024)
Abstract Introduction To date, lung cancer is one of the most lethal diagnoses worldwide. A variety of lung cancer treatments and modalities are available, which are generally presented during the patient and doctor consultation. The implementation o
Externí odkaz:
https://doaj.org/article/ed074b66fd67427fb27af9774867cbe3
Autor:
Gloriana Ndembe, Ilenia Intini, Massimo Moro, Chiara Grasselli, Andrea Panfili, Nicolò Panini, Augusto Bleve, Mario Occhipinti, Cristina Borzi, Marina Chiara Garassino, Mirko Marabese, Simone Canesi, Eugenio Scanziani, Gabriella Sozzi, Massimo Broggini, Monica Ganzinelli
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-18 (2024)
Abstract Background About 10% of NSCLCs are mutated in KRAS and impaired in STK11/LKB1, a genetic background associated with poor prognosis, caused by an increase in metastatic burden and resistance to standard therapy. LKB1 is a protein involved in
Externí odkaz:
https://doaj.org/article/9430de048d034f9d86dd3b0f84f29a05
Autor:
James M. Dolezal, Rachelle Wolk, Hanna M. Hieromnimon, Frederick M. Howard, Andrew Srisuwananukorn, Dmitry Karpeyev, Siddhi Ramesh, Sara Kochanny, Jung Woo Kwon, Meghana Agni, Richard C. Simon, Chandni Desai, Raghad Kherallah, Tung D. Nguyen, Jefree J. Schulte, Kimberly Cole, Galina Khramtsova, Marina Chiara Garassino, Aliya N. Husain, Huihua Li, Robert Grossman, Nicole A. Cipriani, Alexander T. Pearson
Publikováno v:
npj Precision Oncology, Vol 7, Iss 1, Pp 1-13 (2023)
Abstract Artificial intelligence methods including deep neural networks (DNN) can provide rapid molecular classification of tumors from routine histology with accuracy that matches or exceeds human pathologists. Discerning how neural networks make th
Externí odkaz:
https://doaj.org/article/90c8d0f480c347d78a0bdd3a1cd68a11
Autor:
James M. Dolezal, Andrew Srisuwananukorn, Dmitry Karpeyev, Siddhi Ramesh, Sara Kochanny, Brittany Cody, Aaron S. Mansfield, Sagar Rakshit, Radhika Bansal, Melanie C. Bois, Aaron O. Bungum, Jefree J. Schulte, Everett E. Vokes, Marina Chiara Garassino, Aliya N. Husain, Alexander T. Pearson
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-14 (2022)
Safe clinical deployment of deep learning models for digital pathology requires reliable estimates of predictive uncertainty. Here the authors describe an algorithm for quantifying whole-slide image uncertainty, demonstrating their approach with mode
Externí odkaz:
https://doaj.org/article/3782f0100a0e42dd916744ca0dcd64bc
Autor:
Serena Oliveri, Lucilla Lanzoni, Jorien Veldwijk, G. Ardine de Wit, Serena Petrocchi, Rosanne Janssens, Elise Schoefs, Meredith Y. Smith, Ian Smith, Kristiaan Nackaerts, Marie Vandevelde, Evelyne Louis, Herbert Decaluwé, Paul De Leyn, Hanne Declerck, Francesco Petrella, Monica Casiraghi, Giulia Galli, Marina Chiara Garassino, Charis Girvalaki, Isabelle Huys, Gabriella Pravettoni
Publikováno v:
Frontiers in Psychology, Vol 14 (2023)
BackgroundIn the treatment of Non-Small Cell Lung Cancer (NSCLC) the combination of Immuno- Oncotherapy (IO) and chemotherapy (CT) has been found to be superior to IO or CT alone for patients’ survival. Patients and clinicians are confronted with a
Externí odkaz:
https://doaj.org/article/6b8968101cd04aea83118939fddbb458
Autor:
Filippo de Braud, Valter Torri, Giuseppe Lo Russo, Claudia Proto, Roberto Ferrara, Monica Ganzinelli, Marina Chiara Garassino, Giuseppe Viscardi, Giorgio Trinchieri, Mario Occhipinti, Rita Leporati, Marta Brambilla, Luca Agnelli, Silvia Brich, Francesco Sgambelluri, Roberta Mortarini, Andrea Anichini, Leonardo Provenzano, Daniele Lorenzini, Arsela Prelaj, James Dolezal, Teresa Beninato, Tiziana Triulzi, Alessandra Fabbri, Laura Mazzeo, Andrea Spagnoletti, Vanja Miskovic, Alessandra Laura Giulia Pedrocchi, Francesco Trovo', Sara Manglaviti, Claudia Giani, Paolo Ambrosini, Andrea Franza, John McCulloch, Tommaso Torelli, Giancarlo Pruneri
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 6 (2023)
Background Chemoimmunotherapy represents the standard of care for patients with advanced non-small cell lung cancer (NSCLC) and programmed death-ligand 1 (PD-L1)
Externí odkaz:
https://doaj.org/article/0391ecab2ee246659837c5b760a7cc74
Autor:
Arsela Prelaj, Edoardo Gregorio Galli, Vanja Miskovic, Mattia Pesenti, Giuseppe Viscardi, Benedetta Pedica, Laura Mazzeo, Achille Bottiglieri, Leonardo Provenzano, Andrea Spagnoletti, Roberto Marinacci, Alessandro De Toma, Claudia Proto, Roberto Ferrara, Marta Brambilla, Mario Occhipinti, Sara Manglaviti, Giulia Galli, Diego Signorelli, Claudia Giani, Teresa Beninato, Chiara Carlotta Pircher, Alessandro Rametta, Sokol Kosta, Michele Zanitti, Maria Rosa Di Mauro, Arturo Rinaldi, Settimio Di Gregorio, Martinetti Antonia, Marina Chiara Garassino, Filippo G. M. de Braud, Marcello Restelli, Giuseppe Lo Russo, Monica Ganzinelli, Francesco Trovò, Alessandra Laura Giulia Pedrocchi
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
IntroductionArtificial Intelligence (AI) methods are being increasingly investigated as a means to generate predictive models applicable in the clinical practice. In this study, we developed a model to predict the efficacy of immunotherapy (IO) in pa
Externí odkaz:
https://doaj.org/article/c99b6a5fcaed44e39c58687c3976c7f5
Autor:
Diego Signorelli, Patrizia Ghidotti, Claudia Proto, Marta Brambilla, Alessandro De Toma, Roberto Ferrara, Giulia Galli, Monica Ganzinelli, Giuseppe Lo Russo, Arsela Prelaj, Mario Occhipinti, Giuseppe Viscardi, Valentina Capizzuto, Francesca Pontis, Ilaria Petraroia, Anna Maria Ferretti, Mario Paolo Colombo, Valter Torri, Gabriella Sozzi, Marina Chiara Garassino, Elena Jachetti, Orazio Fortunato
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
PD-L1 in tumor cells is the only used biomarker for anti PD1/PD-L1 immune-checkpoints inhibitors (ICI) in Non Small Cell Lung Cancer (NSCLC) patients. However, this parameter is inaccurate to predict response, especially in patients with low tumor PD
Externí odkaz:
https://doaj.org/article/ab5e8307dc3647979bd096212900848c
Autor:
Christine M. Bestvina, MD, Jennifer G. Whisenant, PhD, Valter Torri, MD, Alessio Cortellini, MD, Heather Wakelee, MD, Solange Peters, MD, PhD, Elisa Roca, MD, PhD, Alessandro De Toma, MD, Fred R. Hirsch, MD, Hirva Mamdani, MD, Balazs Halmos, MD, Oscar Arrieta, MD, Anne-Cecile Metivier, MD, Mary J. Fidler, MD, Jacobo Rogado, MD, Carolyn J. Presley, MD, MHS, Celine Mascaux, MD, Carlo Genova, MD, PhD, Juan Bautista Blaquier, MD, Alfredo Addeo, MD, Giovanna Finocchiaro, MD, Hina Khan, MD, Julien Mazieres, MD, PhD, Floriana Morgillo, MD, PhD, Jair Bar, MD, Avinash Aujayeb, MBBS, Giannis Mountzios, MD, PhD, Vieri Scotti, MD, Federica Grosso, MD, Erica Geraedts, MD, Ardak N. Zhumagaliyeva, MD, PhD, Leora Horn, MD, Marina Chiara Garassino, MD, Javier Baena, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 8, Pp 100335- (2022)
Introduction: The Thoracic Centers International coronavirus disease 2019 (COVID-19) Collaboration (TERAVOLT) registry found approximately 30% mortality in patients with thoracic malignancies during the initial COVID-19 surges. Data from South Africa
Externí odkaz:
https://doaj.org/article/40def45b1dee4cd69aa88c393bc82c35